Span PN - Search Results

1

Tamoxifen sensitivity and estrogen receptor mRNA levels.

Span PN, van Laarhoven HW, Sweep FC. Span PN, et al. Breast Cancer Res Treat. 2010 Jun;121(3):793-4. doi: 10.1007/s10549-009-0696-3. Epub 2009 Dec 25. Breast Cancer Res Treat. 2010. PMID: 20035379 No abstract available.

2

EORTC receptor and biomarker study group report analytical and technical evaluation of a thymidine kinase radio-enzymatic assay in breast cancer cytosols.

Span P, Heuvel J, Romain S, Piffanelli A, Martin PM, Geurts-Moespot A, Sweep F. Span P, et al. Anticancer Res. 2000 Mar-Apr;20(2A):681-7. Anticancer Res. 2000. PMID: 10810340

3

Elevated serum endothelin-1 levels in patients with colorectal cancer; relevance for prognosis.

Peeters CF, Thomas CM, Sweep FC, Span PN, Wobbes T, Ruers TM. Peeters CF, et al. Among authors: span pn. Int J Biol Markers. 2000 Oct-Dec;15(4):288-93. doi: 10.1177/172460080001500402. Int J Biol Markers. 2000. PMID: 11192823 Free article.

4

Vascular endothelial growth factor independently predicts the efficacy of postoperative radiotherapy in node-negative breast cancer patients.

Manders P, Sweep FC, Tjan-Heijnen VC, Geurts-Moespot A, van Tienoven DT, Foekens JA, Span PN, Bussink J, Beex LV. Manders P, et al. Among authors: span pn. Clin Cancer Res. 2003 Dec 15;9(17):6363-70. Clin Cancer Res. 2003. PMID: 14695136

5

Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time.

Span PN, Waanders E, Manders P, Heuvel JJ, Foekens JA, Watson MA, Beex LV, Sweep FC. Span PN, et al. J Clin Oncol. 2004 Feb 15;22(4):691-8. doi: 10.1200/JCO.2004.01.072. J Clin Oncol. 2004. PMID: 14966093

6

The complex between urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancer.

Manders P, Tjan-Heijnen VC, Span PN, Grebenchtchikov N, Geurts-Moespot AJ, van Tienoven DT, Beex LV, Sweep FC. Manders P, et al. Among authors: span pn. Thromb Haemost. 2004 Mar;91(3):514-21. doi: 10.1160/TH03-07-0467. Thromb Haemost. 2004. PMID: 14983227

7

Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma.

Manders P, Tjan-Heijnen VC, Span PN, Grebenchtchikov N, Geurts-Moespot A, van Tienoven DT, Beex LV, Sweep FC. Manders P, et al. Among authors: span pn. Cancer. 2004 Aug 1;101(3):486-94. doi: 10.1002/cncr.20374. Cancer. 2004. PMID: 15274061 Free article.

8

Survivin is an independent prognostic marker for risk stratification of breast cancer patients.

Span PN, Sweep FC, Wiegerinck ET, Tjan-Heijnen VC, Manders P, Beex LV, de Kok JB. Span PN, et al. Clin Chem. 2004 Nov;50(11):1986-93. doi: 10.1373/clinchem.2004.039149. Epub 2004 Sep 13. Clin Chem. 2004. PMID: 15364883

9

The prognostic value of BCAR1 in patients with primary breast cancer.

Dorssers LC, Grebenchtchikov N, Brinkman A, Look MP, van Broekhoven SP, de Jong D, Peters HA, Portengen H, Meijer-van Gelder ME, Klijn JG, van Tienoven DT, Geurts-Moespot A, Span PN, Foekens JA, Sweep FC. Dorssers LC, et al. Among authors: span pn. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6194-202. doi: 10.1158/1078-0432.CCR-04-0444. Clin Cancer Res. 2004. PMID: 15448007

10

Concerns about mammaglobin assays.

Span PN, Grebenchtchikov NI, Geurts-Moespot A, Sweep FC. Span PN, et al. Clin Chem. 2005 Feb;51(2):474-5. doi: 10.1373/clinchem.2004.043331. Clin Chem. 2005. PMID: 15681567 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters